Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 41 Show results per page	View Search Criteria \| Help With Results


1.		Study the Role of Positron Emission Mammography in Pre-Surgical Planning for Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Diagnostic				Closed				25 and over				Other				PEM-06-01 NIH Grant: 5 R44 CA103102-05, NCT00484614

Last Modified: 12/1/2001 First Published: 11/1/1997


2.		Phase II/III Diagnostic Study of Whole Body Fludeoxyglucose F 18 Positron Emission Tomography to Measure the Response to Induction Chemotherapy of Potentially Resectable Lung and Esophageal Carcinomas (Summary Last Modified 12/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Diagnostic				Closed				18 and over				NCI				MSKCC-96079 NCI-G97-1334, NCT00002930

Last Modified: 4/30/2007


3.		Phase II/III Diagnostic Study of C11-Methionine and 2-F18-Fluoro-2-deoxy-D-Glucose (FDG) Positron Emission Tomography (PET) Imaging in Patients With Progressive Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Diagnostic				Closed				Not specified				NCI				MSKCC-97007 NCI-G97-1232, NCT00002981

Last Modified: 12/14/2007 First Published: 11/22/2006


4.		Phase II/III Study of Multimodality Breast Imaging Comprising Digital Mammography, Ultrasound, MRI, and Positron Emission Tomography in Women With Newly Diagnosed Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Diagnostic				Completed				18 and over				NCI				UPCC-12199 UPCC-414500, NCT00194337


5.		Utility of FDG-PET Scan on the Selection of Patients for Resection of Hepatic Colorectal Metastases

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Diagnostic, Treatment				Completed				18 to 75				Other				POLEM (ZonMW DO 945-11017) (ZonMW DO 945-11017), NCT00119899


6.		Usefulness of FDG-PET for Advanced Cervical Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Diagnostic				Closed				no age specified				Other				CTRP024 NSC 92-2314-B-182A-084, NCT00146458


7.		PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Diagnostic				Completed				18 and over				Other				CTA-Control-092493 NCT00201942


8.		PET and MRI in the Follow-up of Neoadjuvant Chemotherapy of Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Diagnostic				Closed				18 and over				Other				P020907 AOR02072, NCT00236275


9.		Predictive Value of FDG-PET-CT Scans for Patients With Lung Cancer Receiving Concurrent Chemo-Radiation

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Diagnostic, Treatment				Temporarily closed				18 and over				Other				06-02-117 TACIR, NCT00522639

Last Modified: 12/3/2008 First Published: 11/4/2005


10.		Phase I/II Study of Positron Emission Tomography Measured Uptake of 11C Topotecan in Patients With Brain Metastases Secondary to Ovarian Cancer, Small Cell Lung Cancer, or Other Cancers

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Diagnostic				Temporarily closed				Over 18				NCI				CASE-CWRU-6Y02 NCT00253461

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute